SE448993B - Forfarande for framstellning av metylen-cykloaminderivat - Google Patents

Forfarande for framstellning av metylen-cykloaminderivat

Info

Publication number
SE448993B
SE448993B SE8005235A SE8005235A SE448993B SE 448993 B SE448993 B SE 448993B SE 8005235 A SE8005235 A SE 8005235A SE 8005235 A SE8005235 A SE 8005235A SE 448993 B SE448993 B SE 448993B
Authority
SE
Sweden
Prior art keywords
methylene
cycloamine
solution
mol
preparation
Prior art date
Application number
SE8005235A
Other languages
English (en)
Swedish (sv)
Other versions
SE8005235L (sv
Inventor
Jr A D Cale
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE8005235L publication Critical patent/SE8005235L/xx
Publication of SE448993B publication Critical patent/SE448993B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8005235A 1979-07-19 1980-07-17 Forfarande for framstellning av metylen-cykloaminderivat SE448993B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/059,092 US4242261A (en) 1979-07-19 1979-07-19 Production of methylene-cycloamines

Publications (2)

Publication Number Publication Date
SE8005235L SE8005235L (sv) 1981-01-20
SE448993B true SE448993B (sv) 1987-03-30

Family

ID=22020801

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005235A SE448993B (sv) 1979-07-19 1980-07-17 Forfarande for framstellning av metylen-cykloaminderivat

Country Status (21)

Country Link
US (1) US4242261A (fr)
JP (1) JPS5625153A (fr)
KR (1) KR840002233B1 (fr)
AU (1) AU538138B2 (fr)
CA (1) CA1128939A (fr)
CH (1) CH646954A5 (fr)
DE (1) DE3027168A1 (fr)
EG (1) EG14720A (fr)
ES (1) ES8106491A1 (fr)
FR (1) FR2461703A1 (fr)
GB (1) GB2058049B (fr)
HK (1) HK385A (fr)
IE (1) IE49945B1 (fr)
IL (1) IL60375A (fr)
IT (1) IT1141609B (fr)
NL (1) NL8004165A (fr)
PH (1) PH15057A (fr)
PT (1) PT71581A (fr)
SE (1) SE448993B (fr)
SG (1) SG26284G (fr)
ZA (1) ZA803778B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540690A (en) * 1982-02-09 1985-09-10 The Upjohn Company 2-(Phenylmethylene)cycloalkylamines and -azetidines
US4652559A (en) * 1982-08-16 1987-03-24 The Upjohn Company 2-(Phenylmethylene)cycloalkyl-azetidines
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
GB8825505D0 (en) * 1988-11-01 1988-12-07 Pfizer Ltd Therapeutic agents
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
IL141769A0 (en) 1998-09-11 2002-03-10 Aventis Pharma Sa Azetidine derivatives, preparation and medicines containing them
FR2783246B1 (fr) * 1998-09-11 2000-11-17 Aventis Pharma Sa Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805810B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6566356B2 (en) * 2000-03-03 2003-05-20 Aventis Pharma S.A. Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
UA83230C2 (ru) * 2003-06-11 2008-06-25 Мерк Энд Ко., Инк. Замещенные производные 3-алкил- и 3-алкенилазетидинов
US7906652B2 (en) * 2005-11-28 2011-03-15 Merck Sharp & Dohme Corp. Heterocycle-substituted 3-alkyl azetidine derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130532C (fr) * 1961-02-09
US3192221A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones and production thereof
US3192206A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-aminoalkyl)-3, 3-disubstitutedn-hydrocarbon-2-pyrrolidinones and corresponding-2-thionpyrrolidinones
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
US3458635A (en) * 1966-08-08 1969-07-29 Robins Co Inc A H Compositions containing 3-di-substituted methylene pyrrolidines and methods of treating depression
US3732247A (en) * 1970-08-14 1973-05-08 Robins Co Inc A H 3-di-substituted methylene pyrrolidines wherein the 1-or n-lower-alkyl substituent contains at least two carbon atoms
US4002766A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated Antiarrhythmia methods
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods

Also Published As

Publication number Publication date
IL60375A0 (en) 1980-09-16
SG26284G (en) 1985-03-08
US4242261A (en) 1980-12-30
NL8004165A (nl) 1981-01-21
DE3027168A1 (de) 1981-02-12
IT8068156A0 (it) 1980-07-18
IE49945B1 (en) 1986-01-08
ES493498A0 (es) 1981-07-01
AU538138B2 (en) 1984-08-02
FR2461703A1 (fr) 1981-02-06
EG14720A (en) 1986-03-31
KR830003417A (ko) 1983-06-20
ZA803778B (en) 1981-09-30
KR840002233B1 (ko) 1984-12-06
FR2461703B1 (fr) 1983-04-22
JPS5625153A (en) 1981-03-10
DE3027168C2 (fr) 1990-07-05
JPS643186B2 (fr) 1989-01-19
HK385A (en) 1985-01-11
PH15057A (en) 1982-06-03
GB2058049A (en) 1981-04-08
IT1141609B (it) 1986-10-01
CA1128939A (fr) 1982-08-03
PT71581A (en) 1980-08-01
AU6061780A (en) 1981-01-22
ES8106491A1 (es) 1981-07-01
IL60375A (en) 1983-07-31
CH646954A5 (fr) 1984-12-28
IE801488L (en) 1981-01-19
GB2058049B (en) 1983-09-07
SE8005235L (sv) 1981-01-20

Similar Documents

Publication Publication Date Title
SE448993B (sv) Forfarande for framstellning av metylen-cykloaminderivat
HU184842B (en) Process for producing new 1-bracket-1,3-dioxolan-2-y1-methyl-bracket closed-1h-1,2,4-triazole derivatives
GB2061272A (en) Morpholine Derivatives
US4369184A (en) 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
GB2132605A (en) 2-piperazinone derivatives
US3974156A (en) 2-(Substituted anilino) methylmorpholine compounds
SE448994B (sv) Farmakologiskt aktiva 3-metylenazetidinderivat
HU203722B (en) Process for producing substituted hydroxyamines and pharmaceutical compositions containing them
RU2276152C1 (ru) R-(-)-1-[2-(7-ХЛОРБЕНЗО[b]ТИОФЕН-3-ИЛМЕТОКСИ)-2-(2,4-ДИХЛОРФЕНИЛ)ЭТИЛ]-1H-ИМИДАЗОЛ И ЕГО СОЛИ, СПОСОБ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ПРОТИВОГРИБКОВЫМ ДЕЙСТВИЕМ
NO165104B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
US4831151A (en) Antimicrobial imidazolium derivatives
EP3741744B1 (fr) Intermédiaire pharmaceutique pour la préparation de pimavansérine
US4808727A (en) Imidazolium hydrogen carbonates
SE435507B (sv) Forfarande for framstellning av trimetoxifenoxi-propyl-piperezinderivat
US4607045A (en) Azolylmethylcycloacetals, their preparation and their use as drugs
US4013658A (en) Synthesis of 3,5-diphenyl-4(1h)-pyridazinones
SU545257A3 (ru) Способ получени 1-замещенных пиразолонов-5 или их солей
US4267187A (en) Aminopropanol derivatives of 2-(0-hydroxyphenyl)-pyrrole
CA1294274C (fr) Methode de traitement de la tension musculaire, de la spasticite musculaire et de l'anxiete a l'aide de 3-aryloxy-azetidinecarboxamides
US4029786A (en) Morpholine derivatives for treating depression
Fielden et al. Synthesis and central nervous system depressant activity of some 5-(2-substituted alkyl)-2-oxazolidinones
PT86890B (pt) Processo para a preparacao de 1-(1-aril-2-hidroxi-etil-)-imidazois e dos seus sais e de composicoes farmaceuticas que os contem
US3268533A (en) 4-aminophenylcyclopropyl ketones
JPS62270579A (ja) 4−置換オクタヒドロキノリジン鎮痛性化合物およびオクタヒドロキノリジニウム中間体
DK156653B (da) Fremgangsmaade til fremstilling af methylen-cycloaminer

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8005235-0

Effective date: 19920210

Format of ref document f/p: F